Cornell Researchers Have Discovered a New Extremely Frequent Subtype of Prostate Cancer
A novel and very common form of prostate cancer A new study by experts at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine reveals that around 30 percent of hormone-resistant prostate cancer patients include a previously undiscovered subtype. Recent publication of the paper in the journal Science. This finding may allow individuals with this kind of prostate cancer to get tailored treatments. Source Before this current study, which was headed by Yu Chen, only two kinds of prostate cancer had been identified: androgen-dependent and neuroendocrine. Dr. Chen is an MSK physician-scientist, an associate professor at Cornell, and a member of the Human Oncology and Pathogenesis Program. Dr. Chen's team has dubbed the newly detected third subtype of prostate cancer stem cell-like because several of the genes that are activated in the cells are comparable to those in stem cells (SCL). Dr. Chen and his colleagues examined forty unique prostate cancer models taken from